Your shoulder X-ray shows a white spot in the rotator cuff, and your provider tells you it’s a calcium deposit. The natural next question – should I treat it? – depends on something most patients never learn about: the stage of the calcification.

Calcific tendinitis of the shoulder (calcium deposits within the rotator cuff tendons) isn’t a static condition. It progresses through distinct phases, and the effectiveness of any treatment – including extracorporeal shockwave therapy (ESWT) – depends heavily on where in that cycle you are. Getting the timing right can be the difference between a treatment that works and one that’s unnecessary.

The Three Stages of Shoulder Calcification

The most widely used staging system comes from Uhthoff and Loehr, who described the lifecycle of calcific tendinitis in three phases:

Stage 1: Formative Phase

In this stage, calcium crystals begin depositing within the tendon fibers. The body is actively laying down calcium in an area of the tendon that has undergone a process called fibrocartilaginous transformation – the tendon cells change character in response to reduced blood supply or mechanical stress.

What it feels like: Mild to moderate shoulder pain, often with overhead activities. Some patients have minimal symptoms during this stage.

What imaging shows: A dense, well-defined, homogeneous calcific deposit with clear borders on X-ray. On ultrasound, the deposit appears as a bright, hard structure with strong acoustic shadowing.

Stage 2: Resting (Quiescent) Phase

The deposit has fully formed and sits within the tendon without actively growing or being reabsorbed. This stage can last months to years. The calcium is “quiet” – biologically inactive.

What it feels like: Variable. Some patients have chronic, low-grade shoulder pain. Others are largely asymptomatic and discover the deposit incidentally on imaging obtained for another reason.

What imaging shows: Similar to the formative phase – a dense, well-defined deposit. The distinction from formative is primarily clinical (stable symptoms, no progression on serial imaging).

Stage 3: Resorptive Phase

The body’s immune system recognizes the calcium deposit and begins breaking it down. Macrophages (immune cells) infiltrate the deposit and absorb the calcium. This is actually the body attempting to heal itself.

What it feels like: This is paradoxically often the most painful stage. The resorption process triggers an intense inflammatory response. Patients may experience sudden, severe shoulder pain that can mimic a rotator cuff tear or even a cardiac event. Night pain is common.

What imaging shows: The deposit appears fluffy, cloudy, or fragmented on X-ray. Borders become indistinct. On ultrasound, the deposit may appear paste-like or semi-liquid rather than hard and well-defined.

Which Stage Responds Best to Shockwave Therapy?

This is where the staging system becomes clinically actionable for anyone considering shockwave therapy for calcific shoulder tendinitis.

Formative and resting stages: Best candidates for ESWT. During these phases, the calcific deposit is stable and the body’s natural resorption mechanism hasn’t kicked in. ESWT can help by:

  • Disrupting the crystalline structure of the deposit, making it easier for the body to reabsorb
  • Stimulating neovascularization (new blood vessel growth) in the surrounding tendon
  • Triggering an inflammatory cascade that initiates the resorption process the body hasn’t started on its own

A systematic review by Defined et al. (2017, International Journal of Surgery) found that ESWT achieved partial or complete calcium resorption in 60-80% of patients with formative or resting-stage deposits, with corresponding pain improvement.

Resorptive stage: ESWT may be unnecessary. If the body is already actively breaking down the deposit, shockwave therapy may not add meaningful benefit. The intense pain during this phase reflects an inflammatory process that’s actually working – the calcium is being cleared. Treatment during the resorptive phase typically focuses on pain management (analgesics, corticosteroid injection, activity modification) rather than interventions targeting the deposit itself.

The exception: Some deposits begin resorption, stall partway through, and leave behind a partially dissolved residual deposit that continues to cause symptoms. In these cases, ESWT may help restart or complete the resorption process.

Imaging: How Your Provider Determines the Stage

Before recommending ESWT, your provider should assess the stage of your calcification using imaging. The two primary tools:

X-ray (radiograph): The first-line imaging study. Shows the size, shape, density, and border characteristics of the deposit. Dense deposits with sharp borders suggest formative/resting stages. Fluffy or fragmented deposits suggest resorption.

Ultrasound: More detailed than X-ray for assessing deposit consistency. Can distinguish between hard, chalk-like deposits (formative/resting) and soft, paste-like deposits (resorptive). Also evaluates the surrounding tendon for tears, inflammation, and structural integrity.

The deposit’s characteristics on imaging directly influence whether ESWT is recommended and what outcome you can expect. Understanding the differences between focused and radial shockwave therapy also matters here, since focused ESWT can deliver energy more precisely to deeper deposits.

ESWT vs. Barbotage: Choosing by Stage

For calcific shoulder tendinitis, two non-surgical interventions dominate the clinical landscape:

ESWT (extracorporeal shockwave therapy): Non-invasive, no needles, applied externally through the skin. Works best on hard, well-defined deposits in the formative or resting stage. Requires 3-6 sessions, typically spaced one to two weeks apart.

Barbotage (ultrasound-guided needling and aspiration): Minimally invasive – a needle is inserted into the deposit under ultrasound guidance to fragment and aspirate (suction out) the calcium. Works best on larger deposits and may be preferred when the deposit has a partially liquefied consistency. Usually a single procedure.

The choice often comes down to stage, deposit consistency, and patient preference:

Factor ESWT May Be Preferred Barbotage May Be Preferred
Deposit stage Formative, resting Resting (large), early resorptive
Deposit consistency Hard, chalk-like Soft, paste-like (aspiratable)
Invasiveness preference Non-invasive Tolerant of needle procedure
Number of sessions 3-6 Usually 1

Many providers offer both options and can help you decide based on your imaging findings.

When to Skip Treatment Entirely

Not every shoulder calcification requires intervention. Consider a watchful waiting approach if:

  • Your deposit is small (less than 5mm) and causing minimal symptoms
  • Imaging suggests you’re in the resorptive phase and the deposit is actively dissolving
  • Your pain is manageable with physical therapy and activity modification
  • You’ve only recently developed symptoms (some deposits resolve spontaneously within 12-18 months)

Studies suggest that 25-30% of calcific deposits resolve on their own over time, particularly smaller deposits. However, larger deposits in the formative or resting stage can persist for years without spontaneous resolution – these are the cases where ESWT offers the most clinical value.

The Bottom Line

The stage of your shoulder calcification determines whether shockwave therapy is likely to help. Formative and resting-stage deposits – dense, well-defined, and biologically quiet – are the best candidates for ESWT. Resorptive-stage deposits may be resolving on their own, making shockwave therapy unnecessary. Ask your provider to evaluate your imaging findings and determine which stage applies to you before committing to a treatment plan.

Read our guide to calcific shoulder tendinitis to learn more about ESWT for shoulder calcification.

References

  1. Uhthoff HK, Loehr JW. Calcific tendinopathy of the rotator cuff: pathogenesis, diagnosis, and management. J Am Acad Orthop Surg. 1997;5(4):183-191. PubMed

  2. Gerdesmeyer L, Wagenpfeil S, Haake M, et al. Extracorporeal shock wave therapy for the treatment of chronic calcifying tendonitis of the rotator cuff: a randomized controlled trial. JAMA. 2003;290(19):2573-2580. PubMed